scPharmaceuticals CEO John Tucker's 2019 pay slips 17% to $1.2M

scPharmaceuticals reports 2019 executive compensation

By ExecPay News

Published: April 27, 2020

scPharmaceuticals reported fiscal year 2019 executive compensation information on April 27, 2020.
In 2019, three executives at scPharmaceuticals received on average a compensation package of $657K, a 44% decrease compared to previous year.
Average pay of disclosed executives at scPharmaceuticals
John H. Tucker, Chief Executive Officer, received $1.2M in total, which decreased by 17% compared to 2018. 41% of Tucker's compensation, or $514K, was in salary. Tucker also received $257K in non-equity incentive plan, $181K in option awards, $275K in stock awards, as well as $12K in other compensation.
Rachael Nokes, Senior Vice President of Finance, received a compensation package of $436K. 67% of the compensation package, or $292K, was in salary.
Troy Ignelzi, Chief Financial Officer, earned $296K in 2019, a 67% decrease compared to previous year.

Related executives

John Tucker

scPharmaceuticals

Chief Executive Officer

Rachael Nokes

scPharmaceuticals

Chief Financial Officer

Troy Ignelzi

scPharmaceuticals

Chief Financial Officer

You may also like

Source: SEC filing on April 27, 2020.